Here is yet another video interview with Dr Jeff Sharman about how information presented at ASH2014 is anticipated to impact CLL treatment. Here he discusses the impact of idelalisib and ibrutinib on the treatment of relapsed patients and the relevance of FCR treatment in the older population:
healio.com/hematology-oncol...
Neil
Choice of CLL Treatment Mode of Progression After Frontline Treatment Predicts Clinical Outcomes in Patients With CLLPotential Early Drivers of Disease in Treatment-Naive CLL IdentifiedDr Jeff Sharman - How I Treat My Patients With CLL Who Are Fit or Otherwise HealthyClinical trial results & reviews of new treatments for CLL written in easy to understand terms 
